Novavax, Inc. (NVAX): Price and Financial Metrics
Novavax, Inc. (NVAX)
Today's Latest Price: $111.63 USD
1.48 (1.34%)
Updated Sep 22 4:00pm
Add NVAX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NVAX Stock Summary
- The price/operating cash flow metric for Novavax Inc is higher than 98.16% of stocks in our set with a positive cash flow.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -7.42 for Novavax Inc; that's greater than it is for merely 2.3% of US stocks.
- In terms of volatility of its share price, NVAX is more volatile than 99.06% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Novavax Inc, a group of peers worth examining would be AGIO, SYRS, CNCE, BBIO, and RGNX.
- NVAX's SEC filings can be seen here. And to visit Novavax Inc's official web site, go to www.novavax.com.
NVAX Daily Price Range
NVAX 52-Week Price Range
NVAX Stock Price Chart Technical Analysis Charts
NVAX Price/Volume Stats
| Current price | $111.63 | 52-week high | $189.40 |
| Prev. close | $110.15 | 52-week low | $3.54 |
| Day low | $106.15 | Volume | 2,403,607 |
| Day high | $112.40 | Avg. volume | 8,491,896 |
| 50-day MA | $128.26 | Dividend yield | N/A |
| 200-day MA | $50.77 | Market Cap | 6.84B |
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
Loading social stream, please wait...